Women or non-hypogonadal men.

Any contraindications to testosterone therapy, including:

* History of Breast Cancer

* Severe untreated OSA

* Polycythemia (Hct \>54%)

* Uncontrolled chronic heart failure (CHF)

* A history of a Major Adverse Cardiac Event (MACE) within the past 6 months

* Interest in fertility within 1 year

* An unevaluated PSA \>4.0 ng/mL or a PSA \>3.0 ng/mL in individuals with risk factors for prostate cancer defined as:

* Men with African ancestry

* Men with first-degree relative with prostate cancer

* Known genetic mutations including BRCA1/2

* A history of Lynch Syndrome

* Abnormal DRE

Participants already receiving testosterone or other androgen therapies.

Severe cardiovascular or pulmonary conditions that pose a high surgical risk.

Any condition that, in the opinion of the investigator, would make the subject ineligible for the study.

TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation